Holiferm

The Manchester University spinout runs a commercial Wallasey plant at 1.65 kta, expanding to 3.5 kta and targeting 15 kta; its patented in-fermentation continuous gravity separation cuts OPEX by roughly 50%, making its biosurfactants price-competitive with petrochemical equivalents.

Country: United Kingdom

Coverage

	CN	EU	US
specialty-fine-chem	✓	✓	✓

Regulatorsepareachnmpa

Verifiable facts

Fact	Value	Source
Funding	£18.5 million ($23.36 million) in Series B funding	climateinsider.com · cleangrowthfund.com · ofimagazine.com
Capacity	1.65 kta current capacity, with plans to expand to 3.5 kta and 15 kta	climateinsider.com · holiferm.com · iuk-business-connect.org.uk · cleangrowthfund.com · discover.ukri.org · ofimagazine.com · personalcaremagazine.com
Certification	USDA Certified Biobased Product Label; Ecocert: Cosmos approved	holiferm.com
Production site	Wallasey (commercial plant) and Sci-Tech Daresbury (pilot plant)	climateinsider.com · holiferm.com · iuk-business-connect.org.uk · cleangrowthfund.com · discover.ukri.org · ofimagazine.com · personalcaremagazine.com
Headcount	approximately 60 employees	iuk-business-connect.org.uk · discover.ukri.org

Independent sources: cleangrowthfund.com · climateinsider.com · discover.ukri.org · iuk-business-connect.org.uk · ofimagazine.com · personalcaremagazine.com

Technologies

Name	Cluster	Risk
Biosurfactants	specialty-fine-chem	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.